naproxen has been researched along with muramidase in 10 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (muramidase) | Trials (muramidase) | Recent Studies (post-2010) (muramidase) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 23,777 | 207 | 5,249 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, M; Suzuki, Y; Yamagami, I | 1 |
Dinarello, CA; Gallin, JI; Klempner, MS | 1 |
Bruins, AP; de Zeeuw, D; Franssen, EJ; Kellogg, RM; Koiter, J; Kruizinga, WH; Kuipers, CA; Meijer, DK; Moolenaar, F | 1 |
de Zeeuw, D; Franssen, EJ; Meijer, DK; Moolenaar, F; van Amsterdam, RG; Visser, J | 1 |
Bakke, O; Haneberg, B; Solberg, CO; Sørnes, S | 1 |
de Zeeuw, D; Franssen, EJ; Meijer, DK; Moolenaar, F | 1 |
de Jong, PE; de Zeeuw, D; Haas, M; Kluppel, AC; Meijer, DK; Moolenaar, F; Wartna, ES | 1 |
de Jong, PE; de Zeeuw, D; Haas, M; Meijer, DK; Moolenaar, F | 1 |
Ferreira, JM; Kannan, S; Mishra, SK; Raveendran, S | 1 |
Kannan, S; Mary, DS; Mishra, SK | 1 |
10 other study(ies) available for naproxen and muramidase
Article | Year |
---|---|
Mechanism of action of a new anti-inflammatory agent, naproxen (II). Effects of naproxen on activities of mucopolysaccharase, acid protease and collagenolytic enzymes in inflamed tissues.
Topics: Adenosine Triphosphatases; Animals; Anti-Inflammatory Agents; Exudates and Transudates; Female; Glucuronidase; Glycosaminoglycans; Granuloma; Inflammation; Lyases; Microbial Collagenase; Muramidase; Naphthaleneacetic Acids; Naproxen; Protease Inhibitors; Rats; Time Factors | 1976 |
Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.
Topics: Cations, Divalent; Cytochalasin B; Humans; Indomethacin; Lactoferrin; Leukocytes; Lysosomes; Muramidase; Naproxen; Neutrophils; Phagocytosis; Pyrogens | 1978 |
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
Topics: Amino Acids; Animals; Chromatography, High Pressure Liquid; Drug Carriers; Endopeptidases; Hydrogen-Ion Concentration; Kidney Cortex; Lactates; Lactic Acid; Leucine; Lysosomes; Male; Molecular Weight; Muramidase; Naproxen; Oligopeptides; Proteins; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Succinimides | 1992 |
Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Cyclooxygenase Inhibitors; Drug Carriers; Guinea Pigs; Kidney; Kidney Cortex; Lysine; Male; Molecular Weight; Muramidase; Naproxen; Protein Binding; Rats; Rats, Inbred Strains; Tissue Distribution | 1991 |
Inhibition of in vitro lysozyme release from human granulocytes and monocytes by non-steroidal anti-inflammatory agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Granulocytes; Humans; In Vitro Techniques; Indomethacin; Monocytes; Muramidase; Naproxen | 1987 |
Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
Topics: Anesthesia; Animals; Drug Carriers; Gamma Cameras; Iodine Radioisotopes; Isotope Labeling; Kidney; Kidney Cortex; Lactates; Lactic Acid; Lysosomes; Male; Molecular Weight; Muramidase; Naproxen; Rats; Rats, Wistar; Tissue Distribution | 1993 |
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Female; Iodine Radioisotopes; Kidney Diseases; Kidney Tubules, Proximal; Kinetics; Male; Muramidase; Naproxen; Rats; Rats, Wistar; Tissue Distribution | 1997 |
Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Diuretics; Drug Carriers; Furosemide; Kidney; Male; Muramidase; Naproxen; Natriuresis; Rats; Rats, Wistar; Urination | 1998 |
In Situ Impregnation of Silver Nanoclusters in Microporous Chitosan-PEG Membranes as an Antibacterial and Drug Delivery Percutaneous Device.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Biofilms; Cattle; Cell Line, Tumor; Chickens; Chitosan; Drug Carriers; Drug Liberation; Elastic Modulus; Escherichia coli; Humans; Hydrogen Peroxide; Membranes, Artificial; Metal Nanoparticles; Muramidase; Naproxen; Particle Size; Polyethylene Glycols; Silver; Staphylococcus aureus; Surface Properties | 2016 |
Copper incorporated microporous chitosan-polyethylene glycol hydrogels loaded with naproxen for effective drug release and anti-infection wound dressing.
Topics: Anti-Bacterial Agents; Bandages; Cell Adhesion; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Copper; Drug Carriers; Drug Liberation; Humans; Hydrogels; Hydrogen Peroxide; Mechanical Phenomena; Muramidase; Naproxen; Polyethylene Glycols; Porosity; Steam; Wound Healing | 2017 |